The 2026 Radiopharmaceutical Landscape: The Rise of Theranostic Precision and Molecular Targeting
In 2026, the global medical community has fully embraced the "See it, Treat it" paradigm. The Radiopharmaceutical Market has evolved from a niche diagnostic support sector into a primary pillar of personalized oncology and neurology. By combining diagnostic radioisotopes with therapeutic counterparts—a concept known as theranostics—clinicians can now visualize the exact...
0 Yorumlar 0 hisse senetleri 10 Views 0 önizleme